What is the new treatment approved by the NHS for vitiligo?

The NHS has approved ruxolitinib, a cream designed to restore lost skin colour for individuals with vitiligo.

How effective is the new vitiligo cream in clinical trials?

Clinical trials showed that many patients experienced at least a 75 per cent restoration of colour on affected facial areas after six months of treatment.

Who is eligible for the new ruxolitinib cream treatment in the UK?

Nearly 100,000 patients in the UK aged 12 and over who have vitiligo will be eligible for the new cream.

Home / Health / Breakthrough Vitiligo Cream Approved by NHS

Breakthrough Vitiligo Cream Approved by NHS

24 Feb

•

Summary

New cream ruxolitinib offers first-ever skin colour restoration.
Nearly 100,000 eligible UK patients aged 12+ can access treatment.
Clinical trials show over 75% facial colour restoration in six months.

Breakthrough Vitiligo Cream Approved by NHS

A new cream, ruxolitinib, has been approved by the NHS to treat vitiligo, offering the first-ever possibility of restoring lost skin colour for affected individuals. This groundbreaking treatment will become available to nearly 100,000 Britons aged 12 and over who have the autoimmune condition, which causes white patches on the skin.

Experts consider the cream, applied twice daily, to be life-changing, especially for those whose vitiligo impacts the face, a factor known to profoundly affect confidence and mental health. Clinical trials demonstrated that many patients achieved at least a 75 per cent restoration of colour on their faces within six months.